Stock Market News18 hours KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 Zacks
Krystal Biotech reports initial data from a phase I/II study showing therapeutic benefit in NSCLC patients treated with its immunotherapy candidate, KB707.
X16 hours 4 Biotech Stocks Most Wall Street Analysts Are Bullish About Zacks
X21 hours Merck Enters Obesity Space, Buys Rights to Hansoh’s Oral GLP-1 Drug Zacks
X1 day Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval Investor's Business Daily
X2 days Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks
X2 days 3 No-Brainer Biotech Stocks to Buy With $200 Right Now Yahoo Finance
X2 days Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks
X3 days How to play a potential biotech breakout in 2025 with options CNBC
X3 days 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks
X3 days 3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025 Zacks
X4 days ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks
X4 days ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks
X4 days Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 Yahoo Finance
X7 days KRYS Stock Down on Initial Clinical Updates on KB407 & KB408 Zacks
X1 week RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead MarketWatch
X1 week The Ultimate Biotech Stock to Buy With $500 Right Now Yahoo Finance
X1 week Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks
X1 week Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More Zacks
X1 week Investors Slaughter Q32 Bio On A ‘Messy’ Update In Eczema, Alopecia Treatment Investor's Business Daily
X1 week Candel Skyrockets 68% On A Potential First-In-20-Years Cancer Drug Investor's Business Daily
X1 week Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks
X1 week NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug Investor's Business Daily
X1 week CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease MarketWatch
X1 week Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks
X1 week Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Zacks
X2 weeks Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. Investor's Business Daily
X2 weeks Wuxi, China biotech stocks surge on hopes of less severe US sanctions Investing.com
X2 weeks 2 Biotech Stocks to Buy Hand Over Fist in December Yahoo Finance
X2 weeks CRL Stock to Gain From the Global Biotech Incubator Program Launch Zacks
X2 weeks MacroGenics: A Productive Biotech With Growing Potential – Still Not A Buy Seeking Alpha
X2 weeks Legend Biotech: The Story Brightens Seeking Alpha
X2 weeks Pfizer Stock Falls 8% in a Month: Should You Buy the Dip? Zacks
X2 weeks Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report? Zacks
X2 weeks Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC Zacks
X2 weeks Roivant Sciences: A Biotech Growth Play With Major Ambitions Seeking Alpha
X2 weeks PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy Zacks
X2 weeks Should You Invest in the iShares Biotechnology ETF (IBB)? Zacks
X3 weeks Should You Invest in the SPDR S&P Biotech ETF (XBI)? Zacks
X3 weeks 5 Health care stocks for the next 5 years Reddit
X3 weeks Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger The Wall Street Journal
X3 weeks Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65% Yahoo Finance
X3 weeks Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More Zacks
X3 weeks Gilead Stock Surges 44.2% in 6 Months: Time to Buy or Sell? Zacks
X3 weeks Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Zacks
X3 weeks Biotech ETF (XBI) ended a diagonal – Looking for buying dips FXStreet
X3 weeks Corcept Therapeutics: A Most Promising And Compelling Biotech Seeking Alpha
X3 weeks A Post-Mortem on Cassava Sciences Zacks
X3 weeks Mizuho’s Jared Holz on what Trump’s FDA pick means for biotech innovation YouTube
X4 weeks Finding Winners In Biotech, Probably The Riskiest Sector Seeking Alpha
X4 weeks Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals MarketWatch
X4 weeks OK, Here is the main reason that why Biotech companies don’t make money in China Reddit
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.